Assessment of clinical efficacy in a randomized, double-blind study of etanercept and sulphasalazine in patients with ankylosing spondylitis

被引：0
|
作者：
Braun, J. [1 ]
Huang, F. [2 ]
Burgos-Vargas, R. [3 ,4 ]
van der Horst-Bruinsma, I. E. [5 ]
Freundlich, B. [6 ]
Vlahos, B. [6 ]
Koenig, A. S. [6 ]
机构：
[1] Ruhr Univ Bochum, Rheumatol Med Ctr, Bochum, Germany
[2] Chinese Peoples Liberat Army Gen Hosp, Dept Rheumatol, Beijing, Peoples R China
[3] Univ Nacl Autonoma Mexico, Mexico City 04510, DF, Mexico
[4] Gen Hosp, Mexico City, DF, Mexico
[5] Vrije Univ Amsterdam Med Ctr, Dept Rheumatol, Amsterdam, Netherlands
[6] Wyeth Res, Collegeville, PA USA
来源：
ARTHRITIS AND RHEUMATISM | 2008年 / 58卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S415 / S415
页数：1
相关论文
共 50 条
  • [31] Efficacy and safety of celecoxib in the treatment of symptoms associated with ankylosing spondylitis: A pooled analysis of three randomized, double-blind studies
    Robbins, J. L.
    Coombs, J. H.
    Lowry, S.
    West, C. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 543 - 544
  • [32] AZAPROPAZONE VERSUS INDOMETHACIN IN A DOUBLE-BLIND TEST WITH PATIENTS WITH ANKYLOSING-SPONDYLITIS
    SADOWSKAWROBLEWSKA, M
    GARWOLINSKA, H
    FILIPOVICZSOSNOWSKA, A
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 1980, 39 (11-1): : 406 - 411
  • [33] Randomized, placebo controlled and double-blind trials of efficacy and safety of adalimumab for treating ankylosing spondylitis: a meta-analysis
    Wang, Hongsheng
    Zuo, Dongqing
    Sun, Mengxiong
    Hua, Yingqi
    Cai, Zhengdong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2014, 17 (02) : 142 - 148
  • [34] Disease-modifying effect of etanercept versus sulphasalazine on spinal mobility in patients with ankylosing spondylitis
    Hendrix, Suzanne
    Koenig, Andrew
    Li, Wenzhi
    Singh, Amitabh
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2013, 41 (05) : 1606 - 1611
  • [35] The effects of nanocurcumin on Treg cell responses and treatment of ankylosing spondylitis patients: A randomized, double-blind, placebo-controlled clinical trial
    Ahmadi, Majid
    Hajialilo, Mehrzad
    Dolati, Sanam
    Eghbal-Fard, Shadi
    Heydarlou, Hanieh
    Ghaebi, Mahnaz
    Ghassembaglou, Arezou
    Aghebati-Maleki, Leili
    Kafil, Hossein Samadi
    Kamrani, Amin
    Rahnama, Badrossadat
    Rikhtegar, Reza
    Yousefi, Mehdi
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2020, 121 (01) : 103 - 110
  • [36] SULINDAC AND INDOMETHACIN IN THE TREATMENT OF ANKYLOSING-SPONDYLITIS - A DOUBLE-BLIND CROSSOVER STUDY
    GIBSON, T
    LAURENT, R
    RHEUMATOLOGY AND REHABILITATION, 1980, 19 (03): : 189 - 192
  • [37] Results of a randomized, double-blind study to evaluate the efficacy and safety of etanercept in patients with psoriasis and psoriatic arthritis: the PRESTA trial
    Sterry, W.
    Ortonne, J. -P.
    Kirkham, B.
    Robertson, D.
    Molta, C.
    Pedersen, R.
    Freundlich, B.
    BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (06) : 1410 - 1411
  • [38] DOUBLE-BLIND TRIAL OF NAPROXEN AND PHENYLBUTAZONE IN ANKYLOSING-SPONDYLITIS
    VANGERWEN, F
    VANDERKORST, JK
    GRIBNAU, FWJ
    ANNALS OF THE RHEUMATIC DISEASES, 1978, 37 (01) : 85 - 88
  • [39] A randomized, double-blind, placebo-controlled trial of (Enbrel®) in the treatment of Ankylosing Spondylitis.
    Gorman, JD
    Sack, KE
    Davis, JC
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S90 - S90
  • [40] Efficacy and Safety of Tofacitinib in Ankylosing Spondylitis: A Randomised, Double-blind, Placebo-controlled Trial
    Harish, B., V
    Sahoo, Rasmi Ranjan
    Gochhait, Samanyoya
    Patro, Pradeepta Sekhar
    INDIAN JOURNAL OF RHEUMATOLOGY, 2025, 20 (01) : 27 - 34
12345